To meet ISVAP's Italian insurance regulations, BNL Vita required a single solution that could cover all its valuation needs and provide consistent and reliable processes when valuing non-liquid instruments. FastVal provides a customized output report to help BNL Vita consider key elements of calculations, such as credit and liquidity spread. In addition, it offers reporting views that enable valuations to be decomposed on single derivative elements. BNL Vita also needed a solution which could be implemented in a short timeframe. With FastVal 3.0 delivered on as ASP basis, BNL Vita was able to run valuations on portfolios containing vanilla and complex instruments within two months.
Maurizio Pellicano, general manager of BNL Vita, said, "We required a single valuation solution to help us increase efficiency, improve transparency and meet our national regulatory requirements. Thanks to SunGard, we were able to go live with FastVal within a tight deadline. Now that implementation is complete, we can rely on FastVal's independent valuation solution to help us reduce our operational risk.â
Gavin Lee, chief operating officer of SunGardâs FastVal business unit, said, âBNL Vita needed a solution to provide greater transparency in the way its OTC portfolios are valued. The completion of this implementation has further strengthened our relationship with BNL Vita, and the flexibility of the solution will help the company to evolve with future changes in the industry."